Interventional Cardiology Devices Market Global industry analysis and forecast (2018-2026) – Markets Gazette

Interventional Cardiology Devices Market is expected to reach US$ 25.5 Bn by 2026 at a CAGR of 7.5 % during the forecast period. Interventional cardiology is a branch of cardiology that offers precisely with the catheter-based treatment of structural coronary heart diseases. The principal advantages of using the interventional cardiology are the avoidance of the scars, pain and long post-operative healing. Interventional Cardiology Devices Market

An increasing prevalence of cardiovascular diseases, an increase in patient awareness, unhealthy lifestyle habits such as high alcohol consumption, lack of physical exercise, smoking would create commercial market opportunities. Moreover, numerous instances related to product failure and a product recall is expected to restrain the demand for these techniques within the near future.

According to WHO report, cardiovascular diseases are the major reason 17.7 million deaths have happened in 2015 due to the same. Consequently, for investors, an interventional cardiology devices segment is definitely the right investment avenue, which will give good returns over a period of time.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/13745

Interventional cardiology devices market is segmented by type and region. Among type, angioplasty balloon and angioplasty stent accounted for the largest share in 2015, an angioplasty balloon is projected to develop at the maximum growth rate in the coming future due to rising demand for minimally invasive procedures for coronary artery diseases.

Among regions, the North America region is expected to grow at the highest CAGR during the forecast period due to the presence of favorable government initiatives, increasing new product development, increasing incidence of cardiovascular diseases, and surge in the demand for minimally invasive devices. The APAC region is expected to grow at the highest CAGR during the forecast period due to rising healthcare expenditure, the presence of large untapped opportunities, cardiovascular disease incidence rate, and disposable income levels.

The key players of the Interventional Cardiology Devices Market include Abbott Laboratories (US), Medtronic (US), Boston Scientific (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany).

Abbott labs have visible sturdy sales boom within the recent past, primarily reflecting the effect of acquisitions it made during the last couple of years. Abbott is seeing sturdy development in its medical devices and generic pharmaceuticals business. The company expects this trend to continue in the near future. In 2018, Abbotts Diagnostics business to see a sharp rise in revenues to the north of $7 billion. Primarily due to the influence of the Alere acquisition.

Boston Scientific Company has Cardiovascular and Cardiac Rhythm Management (CRM) as two of its three reportable segments. Cardiovascular includes Interventional Cardiology and Peripheral Interventions businesses. The company is one of the prominent players in the Interventional Cardiology Devices Market with its coronary stent product offerings. Over the past three months, Boston Scientific outperformed its industry. The stock has improved 19.9% compared with the industrys 7.5% gain during the period.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/13745

The scope of the Interventional Cardiology Devices Market report:

Interventional Cardiology Devices Market, By Type:

Angioplasty Balloons Angioplasty Stents Catheters Plaque Modification Devices Hemodynamic Flow Alteration Devices Other Interventional Cardiology Devices

Interventional Cardiology Devices Market, By Region

North America Europe APAC Latin America MEA

Key Players of the Interventional Cardiology Devices Market:

Abbott. Acrostak Int. B. Braun Melsungen AG. Biosensors International Ltd. Boston Scientific Corporation. Cordis Corporation. Edwards Lifesciences Corporation. Johnson & Johnson. Medtronic. Terumo Corporation.

Browse Full Report with Facts and Figures of Interventional Cardiology Devices Market Report at: https://www.maximizemarketresearch.com/market-report/interventional-cardiology-devices-market/13745/

MAJOR TOC OF THE REPORT

Chapter One: Interventional Cardiology Devices Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Interventional Cardiology Devices Market Competition, by Players

Chapter Four: Global Interventional Cardiology Devices Market Size by Regions

Chapter Five: North America Interventional Cardiology Devices Revenue by Countries

Chapter Six: Europe Interventional Cardiology Devices Revenue by Countries

Chapter Seven: Asia-Pacific Interventional Cardiology Devices Revenue by Countries

Chapter Eight: South America Interventional Cardiology Devices Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Interventional Cardiology Devices by Countries

Chapter Ten: Global Interventional Cardiology Devices Market Segment by Type

Chapter Eleven: Global Interventional Cardiology Devices Market Segment by Application

Chapter Twelve: Global Interventional Cardiology Devices Market Size Forecast (2019-2026)

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Here is the original post:

Interventional Cardiology Devices Market Global industry analysis and forecast (2018-2026) - Markets Gazette